AU2021104239A4 - Effects of Ganoderma lucidum fermentation on the main chemical components in mulberry leaves α- Effects of glucosidase inhibitors on their properties - Google Patents
Effects of Ganoderma lucidum fermentation on the main chemical components in mulberry leaves α- Effects of glucosidase inhibitors on their properties Download PDFInfo
- Publication number
- AU2021104239A4 AU2021104239A4 AU2021104239A AU2021104239A AU2021104239A4 AU 2021104239 A4 AU2021104239 A4 AU 2021104239A4 AU 2021104239 A AU2021104239 A AU 2021104239A AU 2021104239 A AU2021104239 A AU 2021104239A AU 2021104239 A4 AU2021104239 A4 AU 2021104239A4
- Authority
- AU
- Australia
- Prior art keywords
- mulberry leaves
- fermentation
- effects
- fresh
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 240000000249 Morus alba Species 0.000 title claims abstract description 70
- 235000008708 Morus alba Nutrition 0.000 title claims abstract description 70
- 238000000855 fermentation Methods 0.000 title claims abstract description 47
- 230000004151 fermentation Effects 0.000 title claims abstract description 47
- 230000000694 effects Effects 0.000 title claims abstract description 24
- 102000004366 Glucosidases Human genes 0.000 title claims abstract description 17
- 108010056771 Glucosidases Proteins 0.000 title claims abstract description 17
- 239000003112 inhibitor Substances 0.000 title claims abstract description 9
- 240000008397 Ganoderma lucidum Species 0.000 title claims description 21
- 235000001637 Ganoderma lucidum Nutrition 0.000 title claims description 21
- 239000000126 substance Substances 0.000 title claims description 11
- 230000002218 hypoglycaemic effect Effects 0.000 claims abstract description 15
- 238000011160 research Methods 0.000 claims abstract description 12
- 238000012545 processing Methods 0.000 claims abstract description 5
- 230000000813 microbial effect Effects 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 abstract description 27
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 13
- 229940079593 drug Drugs 0.000 abstract description 11
- 230000007246 mechanism Effects 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 208000017667 Chronic Disease Diseases 0.000 abstract 1
- 208000013016 Hypoglycemia Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 28
- 229930013930 alkaloid Natural products 0.000 description 24
- 229930003935 flavonoid Natural products 0.000 description 23
- 235000017173 flavonoids Nutrition 0.000 description 23
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 22
- 150000002215 flavonoids Chemical class 0.000 description 21
- 150000004676 glycans Chemical class 0.000 description 21
- 229920001282 polysaccharide Polymers 0.000 description 21
- 239000005017 polysaccharide Substances 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 239000000523 sample Substances 0.000 description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000002609 medium Substances 0.000 description 13
- 230000005764 inhibitory process Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 11
- 102000004877 Insulin Human genes 0.000 description 11
- 108090001061 Insulin Proteins 0.000 description 11
- 229940125396 insulin Drugs 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 10
- 230000003247 decreasing effect Effects 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 239000002028 Biomass Substances 0.000 description 8
- 150000003797 alkaloid derivatives Chemical class 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 238000010563 solid-state fermentation Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000012086 standard solution Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 229960002442 glucosamine Drugs 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 229940123208 Biguanide Drugs 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- -1 Flavonoids Flavonoids Chemical class 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 206010022489 Insulin Resistance Diseases 0.000 description 3
- 229940100389 Sulfonylurea Drugs 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 150000004283 biguanides Chemical class 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000003914 insulin secretion Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 235000017550 sodium carbonate Nutrition 0.000 description 3
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 2
- YOFWROLHDCVYLS-UHFFFAOYSA-N 1-hydroxypiperidin-4-ol Chemical compound OC1CCN(O)CC1 YOFWROLHDCVYLS-UHFFFAOYSA-N 0.000 description 2
- 229920000298 Cellophane Polymers 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 229960002632 acarbose Drugs 0.000 description 2
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- IFBHRQDFSNCLOZ-IIRVCBMXSA-N 4-nitrophenyl-α-d-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-IIRVCBMXSA-N 0.000 description 1
- 241001288809 Coriolopsis Species 0.000 description 1
- 241001136487 Eurotium Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 244000252132 Pleurotus eryngii Species 0.000 description 1
- 235000001681 Pleurotus eryngii Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 229940123464 Thiazolidinedione Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000021257 carbohydrate digestion Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000004155 insulin signaling pathway Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000001467 thiazolidinediones Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
In recent years, as a global chronic disease, the incidence rate of diabetes has been
increasing rapidly, and it has become the third serious threat to human health after
cancer and cardiovascular and cerebrovascular diseases. Traditional diabetes drugs
are expensive and have great side effects on the body. Therefore, it is safe and
inexpensive to develop new effective multi targets from natural Chinese herbal
medicine a- Glucosidase inhibitors have become a hot topic in recent years.
Mulberry leaf, as a traditional Chinese medicine in China, is used as a traditional
Chinese medicine to control diabetes. It contains a variety of functional
components of hypoglycemia. The mechanism of hypoglycemic effect in mulberry
leaves is characterized by multi-component, multi-target, multi-channel and multi
effect, which has attracted the attention of scholars at home and abroad. However,
the research on mulberry leaves is almost based on its dry leaves, and few
researches on fresh medicine. The project applied microbial fermentation
engineering to the biological processing of fresh mulberry leaves, in order to
enrich the active components of hypoglycemic and improve its efficacy, which has
important theoretical and applied research value.
1
Description
TITLE Effects of Ganoderma lucidum fermentation on the main chemical components in mulberry leaves a- Effects of glucosidase inhibitors on their properties
FIELD OF THE INVENTION This paper proposes a goal detection network of end-to-end multi-scale feature fusion because of the tiny pedestrian target and blocking in pedestrian detection.
Current situation of diabetes and its drug treatment Diabetes mellitus (also known as "diabetes" in traditional Chinese Medicine) is a series of metabolic disorders, such as sugar, fat, protein, water, electrolyte and so on, caused by the absolute or relative deficiency of insulin secretion or the decrease of insulin biological effect caused by genetic and environmental factors. Diabetes is divided into type I diabetes (insulin dependent) and type II diabetes (non insulin dependent). Type I diabetes is usually caused by autoimmune system defects, virus infection, genetic factors and so on. Patients need to rely on insulin injection to survive, which may lead to the occurrence of type I diabetes. Type II diabetes is the main type of diabetes. Its pathogenesis is very complex. It is affected by the interaction of genetic factors and environmental factors, insulin resistance and islets p-Cell dysfunction is closely related to obesity. It is generally believed that it is caused by the relative deficiency of insulin and tissue insensitivity to insulin. Now the most important drugs for diabetes: insulin, biguanides, sulfonylureas and insulin a-Glucosidase inhibitors, etc. Traditional hypoglycemic drugs such as insulin, biguanides and sulfonylureas can reduce blood glucose for a short time, but they often have some side effects on gastrointestinal function, and may make the body dependent. In contrast, the hypoglycemic substances obtained from natural plants usually have the characteristics of mild and long-lasting effects, small side effects, and integrated action mechanism of multi targets, multi components and multi effects
Hypoglycemic components of plants and their hypoglycemic effects Mulberry leaves are cold in nature, sweet and bitter in taste, and have the functions of dispersing wind heat, clearing lung and moistening dryness, clearing liver and improving eyesight. Modem studies have shown that mulberry leaves are rich in a variety of active ingredients and show a variety of biological activities. The clinical results showed that mulberry leaves had the effects of lowering blood sugar, blood lipid and anti inflammation. Mulberry leaves contain flavonoids, alkaloids and polysaccharides.
Plant polysaccharides Plant polysaccharide is a kind of biological macromolecule widely existing in plant roots, stems and leaves. It is composed of many monosaccharide molecules through glycosidic bond polymerization, dehydration,A polyhydroxy polymer containing ketone group or aldehyde group is formed. It has good hypoglycemic function, mainly including: promoting insulin secretion and improving insulin resistance; Regulate the activities of related enzymes; Improve the metabolic disorder of the body; It can promote the synthesis of liver glycogen and inhibit gluconeogenesis.
Flavonoids Flavonoids are a kind of polyphenols widely existing in nature. Its structure is often connected with phenolic hydroxyl, methylamino, methyl, isopentenyl and other functional groups. Flavonoids in insulin sensitive tissues regulate carbohydrate digestion, insulin secretion, insulin signaling pathway and glucose uptake through various intracellular signaling pathways, thus showing good hypoglycemic and improving insulin resistance.
alkaloid Alkaloids are a class of basic organic compounds containing nitrogen. Most of them have complex ring structure, and most of them contain nitrogen in the ring, which has significant bioactivity and is one of the important effective components in medicinal plants. Alkaloids in mulberry leaves is a special deoxygenistein (DNJ) a- The inhibition of glucosidase activity can reduce the peak value of postprandial blood glucose and inhibit the absorption of sugar by small intestine. Objective to establish the characterization method of total flavonoids, total alkaloids and total polysaccharides in fresh mulberry leaves; Probiotics (yeast, lactic acid bacteria, etc.), medicinal fungi (Ganoderma lucidum, Eurotium coronatum, etc.), edible fungi (Pleurotus eryngii, coriolopsis strogii, etc.) were selected to screen the excellent fermentation strains of fresh mulberry leaves; With the help of modem analysis technology, the differences of hypoglycemic components in fresh mulberry leaves before and after fermentation were revealed a- The inhibition rate of glucosidase was used to characterize the hypoglycemic effect of fresh mulberry leaves before and after fermentation; Finally, the structure-activity relationship between the hypoglycemic effect and the composition and structure changes of Hypoglycemic Active Substances in fresh mulberry leaves during microbial transformation was elucidated. Natural hypoglycemic components At present, the main drugs for diabetes are insulin, biguanides, sulfonylureas Glucose inhibitors, thiazolidinediones, etc. Although these drugs can reduce blood glucose in a short time, they often have some side effects, especially on the gastrointestinal tract, and long-term use of the body will produce dependence. In contrast, the hypoglycemic substances extracted from natural plants usually have the characteristics of mild and long-lasting effects, small side effects, and the integrated action mechanism of multi-target, multi component and multi effect.
Research and application of fresh Chinese Medicine Mulberry leaves contain a large number of medicinal active components, macromolecular compounds and trace elements beneficial to human body [2]. In clinical practice, mulberry leaf has long been used as a drug to control diabetes (also known as diabetes). At present, the research on mulberry leaves is based on the dry products of mulberry leaves. There are no studies on the changes of active components and pharmacodynamics of fresh mulberry leaves before and after fermentation. The main reasons are that we do not know enough about the material structure and chemical composition of fresh medicine, and the concentration of active ingredients in fresh medicine is low. In addition, in terms of current science and technology, the cost of cultivation, transportation and storage of fresh medicine is high, the application method of fresh medicine, the backward preservation technology of medicinal materials, and the constraints of its own deterioration and failure, It brings challenges to the research of fresh Chinese medicine. In this project, fresh mulberry leaves are used as raw materials, and on the basis of the existing research on dry preparations of traditional Chinese medicine, a method for analyzing the physical and chemical properties of fresh medicines is established to analyze the differences between dry and fresh traditional Chinese medicine, so as to provide a theoretical basis for the development of fresh preparations of traditional Chinese medicine.
Fermentation processing technology of medicinal plants Traditional fermentation technology mainly uses natural inoculation and multi strain fermentation. The bacteria are fungi and bacteria in natural environment. There are many kinds of microorganisms added in the fermentation process, but the number of bacteria that play a role is limited. In general, the traditional fermentation method is also mixed with other strains, such as,In the process of fermentation, the nutrients in the effective components will be greatly reduced, and the fermentation efficiency will be reduced sharply, and the fermentation products will be easily polluted. Different from traditional Chinese herbal medicine processing, it combines Chinese herbal fermentation with bioengineering and microbiology. With the development of real-time fluorescence quantitative PCR and RNA and the in-depth development of microbial diversity research, it can now be based on the changes of bacterial colony and its composition structure in the process of edible and same source plants, The source and species of medicinal plant fermentation strains are more abundant by using modem fermentation technology to screen out the beneficial bacteria, such as 16sma and 26srdna sequence analysis. The core of solid-state fermentation of mulberry leaves by Ganoderma lucidum is that Ganoderma lucidum can proliferate by using the nutrients in mulberry leaves. The mycelium will produce various enzymes during the process of proliferation. Some components of mulberry leaves will decompose and combine with each other under the action of these metabolic enzymes, and form new active chemical components.
Ways of plant fermentation Traditional Chinese medicine fermentation technology mainly includes liquid deep fermentation and solid fermentation. In the production process, due to the high technological requirements of submerged fermentation, this process will reduce the conversion rate of effective components of traditional Chinese medicine, improve the production cost, and consume a lot of medicinal materials resources. The current expenditure of this research is similar to that of the laboratory. Nowadays, the traditional solid-state fermentation method is still used in traditional Chinese medicine fermentation, so this experiment uses the solid-state fermentation technology. In most cases, solid-state fermentation is a biological reaction process in which there is no or almost no free water and one or more microorganisms ferment in water-insoluble solid substrate with certain humidity. Compared with liquid fermentation, solid-state fermentation has the following advantages: (1)after complex processing procedures, energy saving, fermentation process is more environmentally friendly and green. (2)Simulation of natural growth environment, maintain the growth state of microorganisms. (3)The post-treatment is simple, no need to extract and dry directly, so as to keep the active ingredients in the drug to the maximum extent.
SUMMARY OF THE INVENTION Materials and methods Raw materials and strains Ganoderma lucidum was purchased from CICC (No. 14029), and mulberry leaf was purchased from Kuqa, Xinjiang.
Chemicals and reagents Corn flour (Henan Feitian Agricultural Development Co., Ltd.); Wheat bran (Henan Feitian Agricultural Development Co., Ltd.) rutin standard (Yuanye Biology),Technology Co., Ltd.); Ethanol (Shanghai Aladdin Biochemical Technology Co., Ltd.); Acetone (Shanghai Aladdin Biochemical Technology Co., Ltd.); 4-hydroxypiperidinol (Sinopharm Chemical Reagent Co., Ltd.);
Saturated Wright's salt solution (Sinopharm Chemical Reagent Co., Ltd.); Hydrochloric acid (Sinopharm Chemical Reagent Co., Ltd.), PBS solution (Sinopharm Chemical Reagent Co., Ltd.); Acarbose (Sinopharm Chemical Reagent Co., Ltd.); DNJ (Shanghai Aladdin Biochemical Technology Co., Ltd.); PNPG (Sinopharm Chemical Reagent Co., Ltd.); Glucosamine standard solution (Sinopharm Chemical Reagent Co., Ltd.); Sulfuric acid (Sinopharm Chemical Reagent Co., Ltd.); Sodium hydroxide (Sinopharm Chemical Reagent Co., Ltd.); Acetylacetone (Sinopharm Chemical Reagent Co., Ltd.); Eurlich reagent (Sinopharm Chemical Reagent Co., Ltd.); Sodium carbonate (Sinopharm Chemical Reagent Co., Ltd.); The water is ultrapure water (self made), and the other reagents are analytically pure.
Solid state fermentation of mulberry leaves Weigh 10g fresh mulberry leaves, add corn flour and bran, then add distilled water, adjust the final solid-liquid ratio of medium to 1:4; Stir evenly under natural pH, and sterilize in 120 °C with high pressure steam sterilizer 0 C sterilization for 20 min. After cooling, 2 ml of Ganoderma lucidum seed solution was inoculated, and then 30 ml of Ganoderma lucidum seed solution was placed 0 The control group was not inoculated with microorganisms. On day 0, respectively; 2d ; 4d ; 6d ; 8d ; Ten days later, samples were taken to determine the indicators (including biomass, total flavonoids content, total polysaccharides, total alkaloids content), and three parallel time points were set at each time point.
Determination of biomass Draw the standard curve of glucosamine: weigh an appropriate amount of glucosamine standard accurately after prepare a series of solutions. Then measure the absorption value at 520nm with spectrophotometer. Taking the concentration as the abscissa and the absorption value as the ordinate, the standard curve of glucosamine content was drawn. The membrane culture method was used: a layer of sterile cellophane was laid on the wort plate, 0.5ml spore suspension prepared from the inclined plane was absorbed and laid on the membrane. It was incubated for 7 days under 30 0 C , and then cultured for 14 days after decreased to 25 0 C, The biofilm was peeled off from the cellophane for 80 days 0 C drying is pure bacteria. Weigh 0.3g dry bacteria precisely, add 2 ml of 60% h2so4,25 0 Soak for 24h at room temperature, dilute to Imol / L H2SO4, place in 250ml flask, 9.8 ml x After cooling, neutralize with Imol / L NaOH to pH7, and fix the volume to 100ml. Take 0.5ml (blank is 0.5ml distilled water) and 1ml acetylacetone reagent (1.5ml acetylacetone + 50ml 1.25mol/1 Na2CO3), 90 0 After heating for 1 h at room temperature and cooling in cold water, 1 mleurlich reagent was added and colorimetric determination was carried out at 520 nm.
Determination of flavonoids Draw the standard curve of flavonoids: prepare 0.2mg/ml rutin solution, accurately measure 0, 1, 2, 3, 4 and 5ml of the reference solution, put them into ml volumetric flask, add 0.3ml of 5% sodium nitrite solution, shake and stand for 6minutes 0 Add 0.3ml of 10% aluminum nitrate solution, shake and stand for 6minutes, add 4ml of 4% sodium hydroxide solution, dilute with 70% ethanol to 10ml scale, shake and stand for minutes, The absorbance was measured at 510nm. The standard curve was drawn with absorbance (a) as ordinate and reference concentration (c) as abscissa. The regression equation was y = 13.9x-0.0577 (R2 = 0.9913). Preparation of sample extract: 4.Og mulberry leaves were accurately weighed in a 50ml centrifuge tube, and 40 ml of 70% ethanol solution was added 50°C water bath ultrasonic extraction for 40 minutes, filtration, collection of supernatant, sediment and then repeat the above steps to extract once, combined with supernatant, the sample extract was obtained. 2 ml of mulberry leaf extract was precisely measured and put into a ml measuring flask. 0.3 ml of 5% sodium nitrite solution was added to each flask. The mixture was shaken well and left standing for 6 min; Add 0.3ml of % aluminum nitrate solution, shake up, stand for 6minutes, then add 4ml of 4% sodium hydroxide solution, dilute with 60% ethanol, set volume scale, shakeup, stand for minutes, take 60% ethanol solution as blank, measure the absorbance at 51Onm, calculate the content of total flavonoids.
Determination of polysaccharide content Draw polysaccharide standard curve: prepare 1mg / ml glucose standard solution, take 0, 0.2, 0.4, 0.6, 0.8, 1.ml glucose standard solution respectively, add water to 1ml, add dns1.5ml, and develop color in boiling water bath for minutes. After cooling, add water to 10ml, measure the absorbance at 550nm, and draw the standard curve with the absorbance (a) as the ordinate and the reference concentration (c) as the abscissa. Regression equation: y = 0.7251x 0.0326 (R2 = 0.9956) preparation of sample extract: accurately weigh 4.Og of mulberry leaves to be tested in a 50ml centrifuge tube, add 30ml distilled water, mix well and mix for 80 minutes water bath ultrasound 20 minutes, filter, collect supernatant, sediment. Then repeat the above steps to extract once, combined with supernatant to obtain sample extract.Hydrolysis of the extract: precisely transfer 4ml of mulberry leaf sample solution, put it into a triangular conical flask, add 2ml of 6mol / L HC solution (currently prepared), seal it, heat it on a boiling water bath for 30minutes, take it out to cool it down to room temperature. Adjust the pH value to 8.0 with 6mol / L NaOH solution, fix the volume to 20ml with distilled water and shake up. Take 1.Oml of different grades of mulberry leaves polysaccharide hydrolysate samples, put them into a tube with plug, add water to 2.Oml, add 1.5ml DNS reagent, shake them up, heat them in boiling water bath for minutes, take them out and cool them fast, then use 2.Oml distilled water as blank,measure the absorbance at 550nm with ultraviolet visible spectrophotometer.
Determination of alkaloid content Draw the standard curve of alkaloid: accurately absorb 5ml of 0.4mol/1 mother solution of 4-hydroxypiperidinol standard, add 45ml of 0.05mol/1 hydrochloric acid to dilute it to 0.04mol/1 standard solution, take 0.1, 0.2, 0.4, 0.6, 0.8, 1ml of diluted standard solution respectively when making the standard curve. Add 0.05mol/1 hydrochloric acid solution to prepare 2ml of 0.002, 0.004, 0.008, 0.012, 0.016, 0.02mol/1 solution for standby. Suck 2ml standard substance into ml centrifuge tube, add 3ml of 0.02g/ml Wright's salt solution, and take ice bath for 2hours. After centrifugation at 8000 rpm / min for 10 minutes, the supernatant was skimmed off; and ethyl acetate was added into the centrifugation tube. After centrifugation at 8000 rpm / min for 10 minutes, the precipitate was retained and dissolved in 10 ml of 70% acetone solution. The absorbance of the solution was measured at 523 nm. The standard curve was drawn with absorbance (a) as ordinate and reference concentration (c) as abscissa. Regression equation: y = 22.4555x-0.0196 (R2 = 0.9973). Preparation of sample extract: accurately weigh 5g mulberry leaves to be tested and put them into a 50ml centrifuge tube, add 50ml 25% ethanol-0.05mol/1 hydrochloric acid solution, mix well and mix for 30 minutes water bath ultrasound for 20 minutes, filter and collect the supernatant to obtain the sample extract. The sample extract was concentrated and evaporated to dryness with rotary evaporator, dissolved with 0.05mol/1 hydrochloric acid and diluted to 4ml to obtain the total alkaloids of mulberry leaves to be determined solution. 2ml of the solution to be determined was centrifuged at 8000rpm / min for 10 minutes. The supernatant was put into a 10ml centrifuge tube. 3ml of 0.02g/ml Reynold's salt solution was added and ice bath was used for 2hours. After centrifugation at 8000 rpm / min for 10 minutes, the supernatant was skimmed off, and ethyl acetate was added into the centrifugation tube. After centrifugation at 8000 rpm / min for 10 minutes, the precipitate was retained and dissolved in 10 ml of 70% acetone solution. The absorbance of the solution was measured at 523 nm.
Inhibitors for a- Analysis of inhibition rate of glucosidase The experiment was carried out on 96 well plate. There were four groups in the experiment: blank group (substrate), control group (substrate + enzyme solution), sample blank group (substrate + sample), sample group (substrate +
sample + enzyme solution). First of all, 80% was added into 96 well plate p L (blank group, b), 70 p L (control group C), 60 p L (sample blank group, sb), 80 p L (sample group, s) PBS solution with pH = 6.8; Then, 20 samples were added to the sample group and the sample blank group (sb) p L the inhibitor to be tested (the sample is each extract.The control substance is acarbose, DNJ and rutin); Then added 10 samples to the sample group (s) and the control group (b) p L lU/mL a- Glucosidase; Mix well, 37 0 C. oven activation for 15 minutes; Add another 20 p LIOmmol/LpNPG ; After mixing 37 0 C. oven reaction for 30 minutes; Finally, add 100 p The absorbance of 1Imol / L Na2CO3 solution was determined at 405nm. Inhibitors for a- The inhibition rate of glucosidase was calculated as follows:
Inhibition rate%=AC-AB)-(AS-ASB) (AC-AB) X 100%
1. Fig.1 shows the growth curve of Ganoderma lucidum on dry and fresh mulberry leaves; 2. Fig. 2 shows the polysaccharide content of Ganoderma lucidum fermented on dry and fresh mulberry leaves; 3. Fig. 3 shows the alkaloid content of Ganoderma lucidum fermented on dry and fresh mulberry leaves.
DESCRIPTION OF PREFERRED EMBODIMENT Results and analysis Determination of biomass It can be seen from Fig. 1 that Ganoderma lucidum grows rapidly and logarithmically from day 0 to 8 of fermentation; From the 8th day to the 12th day, the growth rate was gradually stable and reached the peak on the 12th day; After 12 days, the biomass of Ganoderma lucidum began to decline. On day 0 2, the biomass of Ganoderma lucidum cultured in fresh mulberry leaves and dry mulberry leaves was almost the same; From the second day of fermentation, the biomass and growth rate of Ganoderma lucidum cultivated with fresh mulberry leaves were higher than those cultivated with dry mulberry leaves. After the 12th day of fermentation, the biomass of Ganoderma lucidum cultivated with fresh mulberry leaves tended to be the same.
Determination of polysaccharide content From Fig. 2, the fermentation of mulberry leaves by Ganoderma lucidum, the content of polysaccharide generally presents a downward trend. On day 0, the polysaccharide content in fresh mulberry leaf medium (224.18 mg / g) was much higher than that in dry mulberry leaf medium (113.48 mg / g). However, it decreased to 22.08 mg / G on day 10. While the polysaccharide content in dry mulberry leaf medium decreased to 46.76 mg / g. There's a possibility that with time-varying, polysaccharides were decomposed by microorganisms, which reduced the content of polysaccharides, and microorganisms may be easier to use polysaccharides in fresh mulberry leaves.
Determination of alkaloid content From Fig. 3, the alkaloid content in mulberry leaves first increased and then decreased with the increase of fermentation time. The content of alkaloids in fresh mulberry leaf medium was higher than that in dry mulberry leaf medium. On the 8th day of fermentation, the alkaloid content reached the maximum, fresh mulberry leaf medium (12.41 mg / g), dry mulberry leaf medium (8.23 mg / g).
Determination of flavonoids From Fig. 4, with the fermentation time, the flavonoid content in mulberry leaves generally increased first and then decreased. The content of flavonoids in fresh mulberry leaves reached the maximum on the 8th day of fermentation (12.41 mg / g). Dry mulberry leaves reached the maximum on the 6th day of fermentation (8.23 mg / g). Bewteen them, the content of flavonoids in fresh mulberry leaf culture medium was generally higher than that in dry mulberry leaf culture medium. However, it took less time for the content of flavonoids in dry mulberry leaf culture medium to reach the maximum value.
Inhibition of active components in mulberry leaves by Ganoderma lucidum fermentation a- Effect of glucosidase on the activity of glucosidase There was a negative correlation between fermentation time and polysaccharide content in mulberry leaf medium, and a positive correlation between fermentation time and flavonoids and alkaloids content at first, and then a negative correlation. Then, 5 UG / ml flavonoids and alkaloids were prepared, and the effects of alkaloids and flavonoids on fermentation time were determined a- The inhibition efficiency of glucosidase.
From Fig. 5, 5 UG / ml alkaloid has a significant effect on the growth of mice which proves a- The inhibition rate of glucosidase first increased and then decreased as the fermentation time increases. It reached the maximum value of 50.732% on the 8th day, and then the inhibition rate began to decline. The inhibition rate increased rapidly on day 0-2 and 4-6, and tended to be flat on day 2-4. From Fig. 6, 5 UG / ml flavone is the best for the treatment a- With the increase of fermentation time, the inhibition rate of glucosidase tended to be gentle at first and then decreased. It reached the maximum value of 19.072% on the fourth day and then decreased gradually. It can be seen that under the same concentration, the alkaloids have a significant effect on the growth of mice a The inhibitory effect of glucosidase was better than that of flavonoids, and the maximum inhibitory rate appeared later than that of flavonoids.
Conclusion and prospect
By measuring the biomass changes of fresh and dry mulberry leaves fermented by Ganoderma lucidum at different fermentation time, and the content changes of polysaccharides, flavonoids, alkaloids and other active substances so as to found that the fresh mulberry leaves medium was more suitable for the growth of Ganoderma lucidum than the dry mulberry leaves medium. The contents of polysaccharides, flavonoids and alkaloids in fresh mulberry leaf medium were higher than those in dry mulberry leaf medium. With the development of fermentation, the content of polysaccharides in fresh and dry mulberry leaves decreased. Also, the content of flavonoids and alkaloids increased first and then decreased, indicating that the fermentation time was negatively correlated with the content of polysaccharides, and positively correlated with the content of flavonoids and alkaloids first and then negatively correlated. The effect of alkaloids on Fermentation a- The inhibitory effect of glucosidase was obviously enhanced, and flavone was the most effective a- The inhibition of glucosidase changed unsignificant. This study provides a theoretical and experimental basis not only for the current clinical trials and laboratory research of traditional Chinese medicine, but also the research and development of functional foods, the prevention and treatment of diabetes, hyperglycemia and secondary diseases of blood lipids. Future research directions should reduce the toxic and side effects and dependence in the process of drug treatment to the greatest extent; improve the utilization rate of active ingredients in mulberry leaves, also including study the preservation method and transportation way of fresh Chinese medicine as soon as possible, so as to realize the reasonable allocation of resources and reduce waste.
Claims (1)
1. Effects of Ganoderma lucidum fermentation on the main chemical components in mulberry leaves a- Effects of glucosidase inhibitors on their properties, characterized in that, including: The project applied microbial fermentation engineering to the biological processing of fresh mulberry leaves, in order to enrich the active components of hypoglycemic and improve its efficacy, which has important theoretical and applied research value.
Figure 2 Figure 1
Figure 3
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021104239A AU2021104239A4 (en) | 2021-07-16 | 2021-07-16 | Effects of Ganoderma lucidum fermentation on the main chemical components in mulberry leaves α- Effects of glucosidase inhibitors on their properties |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021104239A AU2021104239A4 (en) | 2021-07-16 | 2021-07-16 | Effects of Ganoderma lucidum fermentation on the main chemical components in mulberry leaves α- Effects of glucosidase inhibitors on their properties |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2021104239A4 true AU2021104239A4 (en) | 2021-09-16 |
Family
ID=77666575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2021104239A Ceased AU2021104239A4 (en) | 2021-07-16 | 2021-07-16 | Effects of Ganoderma lucidum fermentation on the main chemical components in mulberry leaves α- Effects of glucosidase inhibitors on their properties |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2021104239A4 (en) |
-
2021
- 2021-07-16 AU AU2021104239A patent/AU2021104239A4/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113413351B (en) | Fermented liquid and fermented polypeptide with whitening and anti-aging effects, and preparation methods and applications thereof | |
CN103146592B (en) | Microzyme converting ginsenoside Rb1 to generate Rd and application thereof | |
CN114276967B (en) | Lactobacillus plantarum HL-16 and application thereof | |
CN101775349B (en) | Health-care vinegar, brewing method and hyperglycemic reduction application thereof | |
CN107319161A (en) | A kind of fermented type selenium-enriched plant feed addictive | |
CN106834141B (en) | A kind of anaerobic fungi and the method with its rice straw production formic acid that ferments | |
CN104357332B (en) | Aspergillus niger JH-2 and application to biotransformation and synthesis of asiatic acid | |
CN114052153B (en) | Multifunctional fermented beverage and preparation method thereof | |
CN112691125B (en) | Pharmaceutical composition for whitening or resisting aging, preparation method thereof and skin care product | |
CN108486002A (en) | The Siraitia grosvenorii endophyte bacterial strain of one plant of extracellular polysaccharide and its produce exocellular polysaccharide method and exocellular polysaccharide application | |
AU2021104239A4 (en) | Effects of Ganoderma lucidum fermentation on the main chemical components in mulberry leaves α- Effects of glucosidase inhibitors on their properties | |
CN106819973A (en) | A kind of preparation method of the mulberry fruit microbial compound preparation with hypoglycemic and bowel relaxing functions | |
CN104593199B (en) | A kind of method utilizing Radix Salviae Miltiorrhizae decoction dregs brewing healthy yellow rice wine | |
CN114767757B (en) | Accurate fermentation method of compound Chinese herbal medicine byproducts and application thereof | |
CN114196586B (en) | Enterococcus mundtii and application thereof in fermenting Chinese herbal medicines | |
CN114209621B (en) | Moisturizing and antioxidant red yeast rice fermentation product and preparation method and application thereof | |
CN105535035A (en) | Inonotus obliquus fermentation culture composition and preparation method thereof | |
CN113249235B (en) | Pichia pastoris for producing beta-D-glucosidase and application thereof | |
CN113332387A (en) | Corn silk fermentation method | |
CN115340952A (en) | Method for improving quality of fermentation mycelium of phyllobacterium ribrum by using honeysuckle stem extract | |
CN104928329B (en) | A kind of Sargassum horneri polysaccharide zymolyte and its application | |
AU2020102037A4 (en) | A method of efficiently increasing the alpha-glucosidase inhibitor content in fresh mulberry leaves by the solid-state fermentation | |
CN117322629B (en) | Preparation method of horseshoe lipid-lowering composition based on fermentation enzymolysis technology | |
CN116270826B (en) | Method for improving activity of rose in reducing blood sugar and blood fat and application | |
CN114875104B (en) | Mulberry leaf ferment stock solution and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) | ||
MK22 | Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry |